MedPlus Health Services subsidiary, Optival Health Solutions Private Limited, has received a seven-day suspension order for a Drug License at one of its Andhra Pradesh stores. The order, issued by the Assistant Director of Drug Control Administration, is effective for a brief period and results in a potential revenue loss of ₹4.28 lacs. The company confirmed the details of the enforcement action, stating that operations are temporarily impacted but the matter is quantifiable in monetary terms.
Regulatory Action Against Subsidiary Store
MedPlus Health Services Limited has disclosed an enforcement action taken against one of its operational units. Optival Health Solutions Private Limited, a subsidiary of the company, was issued an order concerning the suspension of a Drug License for a specific retail location in Andhra Pradesh.
Details of the Suspension Order
The action was initiated by the Assistant Director, District sales licensing Authority, Drugs control Administration, covering the Eluru and West Godavari Districts. The nature of the order involves the Suspension of Drug License for Seven Days for the store situated at Chinthalapudi Road, Eluru.
The official order was received by the company on February 12, 2026. This action was reportedly taken under Rule 65 of the Drugs and Cosmetics Act, 1940, and the associated Rules of 1945.
Financial Impact Assessment
The management has quantified the immediate effect of this temporary closure. The company anticipates a Potential Revenue Loss of Rs 4.28 lacs as a direct consequence of the suspension. The announcement confirms that this impact is quantifiable in monetary terms, providing clear disclosure to investors.
Compliance and Disclosure
MedPlus Health Services affirmed that this disclosure is made in compliance with regulatory requirements, read in conjunction with circulars issued by the authorities. The full details of this regulatory event are being made publicly available on the company’s website and the stock exchange portals.
Source: BSE
